ATE130619T1 - In 3-position nitro-substituierte steroid- derivate. - Google Patents

In 3-position nitro-substituierte steroid- derivate.

Info

Publication number
ATE130619T1
ATE130619T1 AT90309221T AT90309221T ATE130619T1 AT E130619 T1 ATE130619 T1 AT E130619T1 AT 90309221 T AT90309221 T AT 90309221T AT 90309221 T AT90309221 T AT 90309221T AT E130619 T1 ATE130619 T1 AT E130619T1
Authority
AT
Austria
Prior art keywords
alpha
steroid derivatives
substituted steroid
hydrogen
ring
Prior art date
Application number
AT90309221T
Other languages
English (en)
Inventor
Dennis Alan Holt
Mark Alan Levy
Brian Walter Metcalf
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of ATE130619T1 publication Critical patent/ATE130619T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0066—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by a carbon atom forming part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT90309221T 1989-08-23 1990-08-22 In 3-position nitro-substituierte steroid- derivate. ATE130619T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/397,615 US4970204A (en) 1989-08-23 1989-08-23 3-substituted nitro-steroid derivatives as 5-α-reductase inhibitors

Publications (1)

Publication Number Publication Date
ATE130619T1 true ATE130619T1 (de) 1995-12-15

Family

ID=23571932

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90309221T ATE130619T1 (de) 1989-08-23 1990-08-22 In 3-position nitro-substituierte steroid- derivate.

Country Status (12)

Country Link
US (1) US4970204A (de)
EP (1) EP0414530B1 (de)
JP (1) JPH03118325A (de)
KR (1) KR910004652A (de)
AT (1) ATE130619T1 (de)
AU (1) AU640161B2 (de)
CA (1) CA2023610A1 (de)
DE (1) DE69023721T2 (de)
IE (1) IE903032A1 (de)
NZ (1) NZ235001A (de)
PT (1) PT95089A (de)
ZA (1) ZA906666B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5215894A (en) * 1992-02-25 1993-06-01 Merck & Co., Inc. Biological process for producing 17β-N-monosubstituted carbamoyl-11-oxo-4-aza-5-α-androst-3-one testosterone-5-α reductase inhibitors
JPH0641038A (ja) 1992-07-17 1994-02-15 Mitsubishi Kasei Corp カルボン酸誘導体
GB9224148D0 (en) * 1992-11-18 1993-01-06 Smithkline Beecham Corp Compounds
US5561124A (en) * 1992-11-18 1996-10-01 Webb; Robert L. 17-α-acyl steroids which inhibit 5-α-reductase
CA2669753C (en) 1999-09-30 2012-06-26 Hollis-Eden Pharmaceuticals, Inc. Therapeutic treatment of androgen receptor driven conditions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4377584A (en) * 1978-04-13 1983-03-22 Merck & Co., Inc. 4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors
US4191759A (en) * 1978-04-13 1980-03-04 Merck & Co., Inc. N-substituted-17β-carbamoylandrost-4-en-3-one 5α reductase inhibitors
US4317817A (en) * 1979-08-27 1982-03-02 Richardson-Merrell Inc. Novel steroid 5α-reductase inhibitors
DK465481A (da) * 1980-11-21 1982-05-22 Hoffmann La Roche Fremgangsmaade til fremstilling af d-homostemoider
US4814324A (en) * 1987-03-06 1989-03-21 Merck & Co., Inc. Sterol inhibitors of testosterone 5α-reductase
US4910226A (en) * 1987-04-29 1990-03-20 Smithkline Beckman Corporation Steroid 5-alpha-reductase inhibitors
US4946834A (en) * 1988-12-23 1990-08-07 Smithkline Beecham Corporation Phosphonic acid substituted steroids as steroid 5α-reductase inhibitors
US5026882A (en) * 1988-12-23 1991-06-25 Smithkline Beecham Corporation Phosphinic acid substituted steroids as inhibitors of steroid 5α-reductase

Also Published As

Publication number Publication date
PT95089A (pt) 1991-04-18
EP0414530A2 (de) 1991-02-27
DE69023721T2 (de) 1996-04-25
EP0414530B1 (de) 1995-11-22
AU6115190A (en) 1991-02-28
US4970204A (en) 1990-11-13
IE903032A1 (en) 1991-02-27
AU640161B2 (en) 1993-08-19
ZA906666B (en) 1991-09-25
CA2023610A1 (en) 1991-02-24
JPH03118325A (ja) 1991-05-20
NZ235001A (en) 1993-01-27
DE69023721D1 (de) 1996-01-04
KR910004652A (ko) 1991-03-29
EP0414530A3 (en) 1991-07-24

Similar Documents

Publication Publication Date Title
DK0414529T3 (da) Substituerede steroidderivater
DK73594A (da) Fremgangsmåde til fremstilling af 17-substituerede 4-aza-5,7-androstadien-3-on-derivater
ES2039278T3 (es) Procedimiento para preparar inhibidores de 5-alfa-reductasa de esteroides.
MX9301525A (es) Esteriodes substituidos en la posicion 17 y composicion farmaceutica que los contiene.
DK8885A (da) N-heterocyclyl-4-piperidinaminderivater og fremgangsmaade til fremstilling deraf
FI905281A0 (fi) Menetelmä farmakologisesti arvokkaiden fuusioituneiden polysyklisten yhdisteiden valmistamiseksi
SE8103988L (sv) 10-(1,2-propadienyl)steroider och kompositioner innehallande desamma, med terapeutisk anvendning
HUT55385A (en) Process for producing 3-piperazinyl-benzazol derivatives and pharmaceutical compositions containing them as active components
DE69023721D1 (de) In 3-Position Nitro-substituierte Steroid-Derivate.
AU641686B2 (en) Benzanilides
GB1399261A (en) 1,3-diamino 2-propanols and process for their preparation
NO872115D0 (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive steroider.
FI896251A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten pyratsolopyridiinijohdannaisten valmistamiseksi
MX9303392A (es) Derivados de imidazo benzoxazin-1-ona substituidos y proceso para su preparacion.
ES2087173T3 (es) Uso de derivados de piridoindol en el tratamiento de enfermedades isquemicas.
MY104529A (en) New selenophen derivatives, a preparation process of the same and therapeutical compositions containing them
ES2059097T3 (es) Derivados de la ergolina.
LU88449I2 (fr) Fleroxacine et ses dérivés pharmaceutiquement acceptables.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties